Alphatec (NASDAQ:ATEC) reported second-quarter 2026 revenue of $214 million, up 15% from a year earlier, as growth in surgical procedures and surgeon adoption supported higher profitability and positive free cash flow.
Chairman and CEO Pat Miles said surgical revenue rose 17% to $196 million, while
Alphatec bets on integrated spine surgery tech, while Inspire leads in sleep apnea devices with robust profitability. How do their financials and risks stack up?
Penn Capital initiated a position in ACM Research, which supplies cleaning and plating tools used in advanced semiconductor manufacturing. As AI-driven chip designs grow more complex, precision equipment becomes more valuable, but demand remains tied to export controls and capital spending cycles.
Right now, a powerful probability engine is shaping the next wave of market moves - whether most investors realize it or not. These real-money probability signals are often more reliable than analyst forecasts. And I’m going to show you how I use shifts in belief, before prices adjust, to identify high-probability setups in individual stocks.
